Understanding current events through the lenses of the past and future.
Wall Street Journal
Lilly defied the skeptics to push ahead with donanemab. It paid off.
https://www.wsj.com/articles/eli-lilly-donanemab-alzheimers-drug-trial-fda-committee-approval-f59ffcf4
A Guilty Verdict for Hunter Biden Weighs on a Worried President Biden
Elon Musk Withdraws Suit Against OpenAI, Sam Altman
